Continuous Glucose Monitoring (CGM) Market : Key Drivers, Regional Insights & Forecast to 2033

Global Continuous Glucose Monitoring (CGM) Market – Size, Share, Trends, Growth, and Forecast 2025-2033

Market Overview

The Global Continuous Glucose Monitoring (CGM) Market is poised for substantial expansion over the next decade. Estimated at USD 6.82 billion in 2024, the market is projected to reach approximately USD 14.1 billion by 2033, growing at a robust CAGR of 8.41% during the forecast period. The surge is driven by increasing diabetes prevalence, technological advancements in CGM systems, and the global push for better chronic disease management solutions.

Do you want to visit Char Dham? Char Dham Travel Agent is the best place to plan your Char Dham tour. You can book the tour from here.

What is Continuous Glucose Monitoring (CGM)?

Continuous Glucose Monitoring (CGM) is a breakthrough in diabetes management that provides real-time glucose level tracking through a minimally invasive sensor placed under the skin. These sensors measure glucose in interstitial fluid and transmit data to a receiver or smartphone, offering continuous feedback. CGM systems help patients avoid hyperglycemia and hypoglycemia by enabling timely medical interventions. Widely adopted in both homecare and clinical settings, CGMs are becoming central to the management of Type 1 and insulin-dependent Type 2 diabetes.

Market Growth Drivers

Would you like to visit Indiar? A tour operator in India is the best place to plan your tour. You can book a tour from here.

1. Rising Global Diabetes Prevalence

The dramatic rise in both Type 1 and Type 2 diabetes cases globally is a key driver. According to IDF statistics:

537 million adults (aged 20–79) were living with diabetes in 2021.
This figure is expected to rise to 643 million by 2030 and 783 million by 2045.
Over 14% of adults globally were affected by diabetes in 2022, up from 7% in 1990.

This growing patient base is propelling the demand for real-time, accurate glucose monitoring systems like CGMs.

Would you like to visit Haridwar? Travel agents in Haridwar are the best place to plan your trip. You can book your tour right here.

2. Technological Innovations in CGM Systems

Continuous advancements are enhancing device performance, user comfort, and integration with digital platforms. Key innovations include:

Improved sensor accuracy and longevity.
Seamless smartphone compatibility.
Integration with automated insulin delivery systems.
Real-time alerts and predictive analytics.

In August 2024, Abbott partnered with Medtronic to integrate FreeStyle Libre technology with Medtronic’s insulin systems—setting a precedent for future CGM device evolution.

3. Shift Towards Homecare and Personalized Monitoring

The rising preference for home-based healthcare solutions has increased the use of CGM devices. These tools:

Eliminate the need for frequent hospital visits.
Support remote monitoring by healthcare professionals.
Promote patient empowerment and proactive disease management. This trend is especially significant for elderly and pediatric diabetic populations.

Key Market Challenges

1. High Cost of Devices

The affordability of CGM systems remains a barrier, especially in low- and middle-income regions. Ongoing costs for sensors and transmitters can be substantial for uninsured patients, limiting market penetration.

2. Accuracy and Calibration Concerns

Despite significant improvements, discrepancies in sensor readings and occasional calibration requirements may impact user trust and clinical adoption. Ongoing R&D is focused on enhancing accuracy and reducing manual interventions.

Related Report

Segment Analysis

By Component

• Sensors

Sensors are the most critical component of a CGM system, continuously measuring glucose levels. Advancements are improving:

Sensor lifespan
Comfort and wearability
Minimal calibration

Manufacturers are investing in long-lasting, low-cost, and accurate sensors to improve user adherence and expand market reach.

• Transmitters

Transmitters relay glucose data from sensors to display devices. Emphasis is on:

Miniaturization
Battery life
Wireless connectivity

Technological integration with wearables and cloud platforms is a key trend.

• Receivers

Receivers interpret and present glucose data to the user. Trends include:

Use of smartphone apps
Integration with health cloud ecosystems
Improved user interface and trend analytics

Receivers are expected to become more sophisticated, especially in premium CGM systems.

By End User

• Hospitals

Hospitals use CGMs to manage glucose levels in critical care, post-operative recovery, and inpatient diabetes management. Benefits include:

Real-time monitoring
Improved clinical decision-making
Reduction in glucose variability in ICU settings

• Homecare Settings

Homecare represents the fastest-growing end-user segment due to:

Aging population
Growing demand for remote monitoring
Emphasis on cost-effective chronic care management

• Others

This includes outpatient clinics, diabetes care centers, and athletic institutions, which are beginning to adopt CGM for specialized use cases, including performance tracking.

Regional Insights

United States

The U.S. leads the global CGM market due to:

High diabetes prevalence
Advanced healthcare infrastructure
Broad insurance coverage
Strong government support for digital health

CDC estimates show 98 million adults in the U.S. have prediabetes, underlining the urgent need for proactive monitoring solutions like CGMs.

Germany

Germany represents the largest CGM market in Europe, supported by:

Robust insurance reimbursement policies
High healthcare awareness
Government initiatives in diabetes management education

India

India’s CGM market is booming owing to:

Its massive diabetic population
Rising health consciousness
Expansion of low-cost CGM options
Increased use of telemedicine and mobile health platforms

The partnership between Dario Health and Dexcom in 2023 showcases this momentum.

Brazil

Brazil is witnessing increased CGM adoption despite pricing challenges. Growth is driven by:

Government incentives
Collaborations with global tech firms, like the Molex and GlucoModicum partnership on needle-free CGM technology.

UAE

The UAE market benefits from:

High diabetes incidence
Government initiatives promoting digital health
Integration with AI-powered wellness apps like PureHealth’s Pura, emphasizing personalized care

Competitive Landscape

Major Companies Covered